SRTS Wutah pendapatan triwulanan Sensus Healthcare Inc

A stable staff of specialized engineers provides a reliable foundation for Sensus Healthcare, Inc. (SRTS). Quarter-over-quarter revenue growth reflects the expansion of SRT-100 systems into US clinics. The high cost of non-invasive skin cancer treatment supports the premium pricing power of the equipment. Meanwhile, -12.70 serves as the current metric, capturing the actual development pace of the company's commercial model.
Ringkesan rincian data analitis Sensus Healthcare Inc (SRTS)

Fundamental asset selection requires analyzing business expansion rates by comparing current financial results with previous periods. This indicator measures the growth rate of revenue from the sale of radiation therapy systems and consumables, allowing a real-time assessment of Sensus Healthcare (SRTS) market expansion through quarterly sales dynamics and the timely identification of business valuation overheating risks.